3 clinical trials registered. Interventions under study include drug therapy, other interventions, and gene therapy. Pipeline includes 2 PHASE2. Research is primarily sponsored by academic and government institutions.
46 publications have been identified in PubMed for acute myeloblastic leukemia without maturation. Research spans Basic Science / Preclinical (49%), Case Report / Case Series (16%), and Diagnostic / Biomarker (13%).
Mansoori S (2026). [PMID: 41201043](https://pubmed.ncbi.nlm.nih.gov/41201043/). *Oncol Rep*. [Basic Science / Preclinical]
Bilkay M (2026). [PMID: 42165692](https://pubmed.ncbi.nlm.nih.gov/42165692/). *Luminescence*. [Basic Science / Preclinical]
Bajafar A (2026). [PMID: 41798675](https://pubmed.ncbi.nlm.nih.gov/41798675/). *Radiol Case Rep*. [Case Report / Case Series]
Liu C (2026). [PMID: 42014831](https://pubmed.ncbi.nlm.nih.gov/42014831/). *Sci Rep*. [Basic Science / Preclinical]
Qiu R (2026). [PMID: 41915675](https://pubmed.ncbi.nlm.nih.gov/41915675/). *PLoS One*. [Basic Science / Preclinical]
Qian Y (2026). [PMID: 41760705](https://pubmed.ncbi.nlm.nih.gov/41760705/). *Sci Rep*. [Basic Science / Preclinical]
Tripathi A (2026). [PMID: 41688891](https://pubmed.ncbi.nlm.nih.gov/41688891/). *Gut Microbes*. [Basic Science / Preclinical]
Yang M (2026). [PMID: 41881955](https://pubmed.ncbi.nlm.nih.gov/41881955/). *Cell Death Dis*. [Basic Science / Preclinical]
Yang LY (2026). [PMID: 41323205](https://pubmed.ncbi.nlm.nih.gov/41323205/). *Bioact Mater*. [Gene Therapy / Novel Therapeutics]
Shi Z (2026). [PMID: 41710900](https://pubmed.ncbi.nlm.nih.gov/41710900/). *Front Immunol*. [Basic Science / Preclinical]
